Teva Pharmaceutical Industries News

SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(5.537%),Abigail P. Johnson(5.537%)

Nov 12 23:39

10-Q: Q3 2024 Earnings Report

Nov 7 05:15

8-K: Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

Nov 6 20:02

4: Statement of changes in beneficial ownership of securities-Director Shalev Varda

Sep 4 19:45

144/A: Others

Aug 14 19:09

144/A: Others

Aug 14 18:26

4: Statement of changes in beneficial ownership of securities-Officer Daniell Richard

Aug 14 04:13

4: Statement of changes in beneficial ownership of securities-Officer Grant Angus

Aug 14 04:12

4: Statement of changes in beneficial ownership of securities-Officer Hughes Eric A

Aug 14 04:10

144: Notice of proposed sale of securities pursuant to Rule 144

Aug 13 04:12

144: Notice of proposed sale of securities pursuant to Rule 144

Aug 13 04:01

144: Notice of proposed sale of securities pursuant to Rule 144

Aug 10 04:03

4: Statement of changes in beneficial ownership of securities-Officer Hughes Eric A

Aug 5 19:37

4: Statement of changes in beneficial ownership of securities-Officer Jover Placid

Aug 5 19:37

3: Initial statement of beneficial ownership of securities-Officer Jover Placid

Aug 5 19:32

144: Notice of proposed sale of securities pursuant to Rule 144

Aug 2 04:02

10-Q: Q2 2024 Earnings Report

Aug 1 04:11

8-K: Current report

Jul 31 19:06

8-K: Current report

Jun 25 20:05

4: Statement of changes in beneficial ownership of securities-Director MIGNONE ROBERTO

Jun 22 04:07